The HER2-positive rate was 23.3%, and the percentage of each TCGA molecular classification was as follows: MSI (16.7%), EBV (10.0%), GS (13.3%), and CIN (60.0%). Here, ERBB2 is linked to cervical squamous intraepithelial neoplasia.